Document Type

Conference Proceeding

Publication Date



Hepatitis C virus (HCV) is one of the most significant public health problems currently facing the U.S. If it is left untreated, the likelihood of sustaining a treatment response decreases. While early identification has been identified as a critical focus in trying to obtain better health outcomes, new drug treatments appear quite promising.


This paper was presented at the Northeast Business & Economics Association Forty-Fifth Annual Conference, October 25-27, 2018 in Galloway, New Jersey. Presentation slides are included as a supplemental file. Copyright © 2018 The Authors. All rights reserved.

Hep C - NBEA.pdf (246 kB)